Christian Steidl
Christian Steidl
Associate Professor of Pathology, University of British Columbia
Verified email at
TitleCited byYear
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
SP Shah, RD Morin, J Khattra, L Prentice, T Pugh, A Burleigh, A Delaney, ...
Nature 461 (7265), 809, 2009
Tumor-associated macrophages and survival in classic Hodgkin's lymphoma
C Steidl, T Lee, SP Shah, P Farinha, G Han, T Nayar, A Delaney, ...
New England Journal of Medicine 362 (10), 875-885, 2010
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients
D Haase, U Germing, J Schanz, M Pfeilstöcker, T Nösslinger, ...
Blood 110 (13), 4385-4395, 2007
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
NA Johnson, GW Slack, KJ Savage, JM Connors, S Ben-Neriah, S Rogic, ...
Journal of clinical oncology 30 (28), 3452, 2012
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international …
J Schanz, H Tüchler, F Solé, M Mallo, E Luno, J Cervera, I Granada, ...
Journal of Clinical Oncology 30 (8), 820, 2012
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
NA Johnson, KJ Savage, O Ludkovski, S Ben-Neriah, R Woods, C Steidl, ...
Blood 114 (11), 2273-2279, 2009
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
C Steidl, SP Shah, BW Woolcock, L Rui, M Kawahara, P Farinha, ...
Nature 471 (7338), 377, 2011
Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment
C Steidl, JM Connors, RD Gascoyne
Journal of Clinical Oncology 29 (14), 1812-1826, 2011
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing
RD Morin, K Mungall, E Pleasance, AJ Mungall, R Goya, RD Huff, ...
Blood 122 (7), 1256-1265, 2013
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
R Kridel, B Meissner, S Rogic, M Boyle, A Telenius, B Woolcock, ...
Blood 119 (9), 1963-1971, 2012
The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia
A Kuendgen, M Schmid, R Schlenk, S Knipp, B Hildebrandt, C Steidl, ...
Cancer 106 (1), 112-119, 2006
Cooperative epigenetic modulation by cancer amplicon genes
L Rui, NCT Emre, MJ Kruhlak, HJ Chung, C Steidl, G Slack, GW Wright, ...
Cancer cell 18 (6), 590-605, 2010
Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma
R Rahal, M Frick, R Romero, JM Korn, R Kridel, FC Chan, B Meissner, ...
Nature medicine 20 (1), 87, 2014
Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma
DDW Twa, FC Chan, S Ben-Neriah, BW Woolcock, A Mottok, KL Tan, ...
Blood 123 (13), 2062-2065, 2014
Loss of BAF250a (ARID1A) is frequent in high‐grade endometrial carcinomas
KC Wiegand, AF Lee, OM Al‐Agha, C Chow, SE Kalloger, DW Scott, ...
The Journal of pathology 224 (3), 328-333, 2011
Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies
DW Scott, A Mottok, D Ennishi, GW Wright, P Farinha, S Ben-Neriah, ...
Journal of clinical oncology 33 (26), 2848, 2015
Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary …
U Germing, B Hildebrandt, M Pfeilstöcker, T Nösslinger, P Valent, ...
Leukemia 19 (12), 2223, 2005
Essential role of Jun family transcription factors in PU. 1 knockdown–induced leukemic stem cells
U Steidl, F Rosenbauer, RGW Verhaak, X Gu, A Ebralidze, HH Otu, ...
Nature genetics 38 (11), 1269, 2006
Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute …
A Kuendgen, S Knipp, F Fox, C Strupp, B Hildebrandt, C Steidl, ...
Annals of hematology 84 (1), 61-66, 2005
Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial
KL Tan, DW Scott, F Hong, BS Kahl, RI Fisher, NL Bartlett, RH Advani, ...
Blood 120 (16), 3280-3287, 2012
The system can't perform the operation now. Try again later.
Articles 1–20